Go Wish Game to support advance care planning for adults with cancer or blood cancers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This mixed-method, device- and drug-free interventional project uses the Go Wish Game—a deck of cards listing concrete end-of-life priorities—to prompt values-based conversations between patients, caregivers, and clinicians. It enrolls adults (≥18) with refractory lymphomas, leukemia, multiple myeloma, or advanced solid tumors and an estimated prognosis greater than three months who can communicate in Italian and provide written consent. The primary aim is to test the feasibility of delivering the card-based intervention in hematology and oncology settings across participating centers. Quantitative measures and qualitative interviews will capture acceptability, uptake, and whether advance care planning documentation is completed.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ≥ 18 years age; diagnosed with refractory lymphomas, or leukemia or multiple myeloma or advanced solid tumors and estimated prognosis \> 3 months;
* able to communicate in Italian and
* to give written consent to the study.

Exclusion Criteria:

* Patients with severe cognitive impairment or serious psychiatric condition;
* refusal to participate to the study

Where it's running

• AziendaUSL IRCCS Reggio Emilia
  Reggio Emilia, Italy Recruiting

Study contacts

• Study coordinator: Marta Perin (Dr), PhD
• Email: marta.perin@ausl.re.it
• Phone: +39 3463576133

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Home blood transfusions for people with advanced blood cancers in hospice

  The study will test whether offering home blood transfusions to adults with advanced or relapsed blood cancers who are eligible for hospice helps improve quality of life, mood, and end-of-life care.

  Recruiting at 2 sites Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT06487247

• Genetics of Blood Cancers in the U.S. population

  This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.

  Recruiting Rutgers, The State University of New Jersey · Piscataway, New Jersey · NCT07714044

• Cord blood transplant for children and young adults with blood cancers.

  This study will test whether a cord blood transplant given as a first or second transplant can help children and young adults with leukemia, myelodysplasia, or lymphoma who lack a matched donor.

  Recruiting Phase 2 Memorial Sloan Kettering Cancer Center · New York, New York · NCT07566377

• Capivasertib plus venetoclax with low-intensity chemotherapy for adults with lymphoid acute leukemia or lymphoblastic lymphoma

  This will see if adding capivasertib to venetoclax and a low‑intensity chemotherapy regimen helps adults with relapsed or refractory lymphoid acute leukemia or lymphoblastic lymphoma.

  Recruiting Phase 1/2 University of Chicago · Chicago, Illinois · NCT07294677

• Reduced‑dose apixaban or rivaroxaban versus daily low‑molecular‑weight heparin for people with blood cancers

  This trial will test whether reduced‑dose apixaban or rivaroxaban pills can prevent blood clots as well and as safely as daily low‑molecular‑weight heparin injections in people with hematologic malignancies.

  Recruiting Medical University of Gdansk · Gdansk, Pomeranian Voivodeship · NCT07270263

• High-altitude stem cell and bone marrow transplant registry on the Qinghai-Tibet Plateau

  This project will collect clinical data and blood/bone marrow samples from people having hematopoietic stem cell transplants on the Qinghai‑Tibet Plateau to see how high altitude affects transplant outcomes and recovery.

  Recruiting Affiliated Hospital of Qinghai University · Xining, Qinghai · NCT07205523

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.